Table 1 Monthly socio-demographic, antenatal and malaria-related characteristics of the respondents during the study intervention period.
Variable | Month 1 n = 143 (%) | Month 2 n = 158 (%) | Month 3 n = 153 (%) | Month 4 n = 230 (%) | Month 5 n = 155 (%) |
|---|---|---|---|---|---|
Mean age ± SD | 25.8 ± 5.0 | ||||
At least one ANC visit | 111 (77.6) | 147 (93.0) | 127 (83.0) | 177 (77.0) | 136 (87.7) |
Mean number of ANC attended | 2.9 ± 1.4 (n = 111) | 3.0 ± 1.8 (n = 147) | 3.1 ± 1.7 (n = 127) | 3.2 ± 1.5 (n = 177) | 3.0 ± 2.1 (n = 155) |
Ever received IPTp | 80 (55.9) | 105 (66.5) | 130 (85.0) | 164 (71.3) | 133 (85.8) |
Source of IPTp | |||||
PHC | 55 (38.5) | 40 (25.3) | 18 (11.8) | 31 (13.5) | 12 (7.7) |
CDD | 0 (0.0) | 53 (33.5) | 108 (70.6) | 127 (55.2) | 121 (78.1) |
Patent medicine vendor | 24 (16.8) | 12 (7.6) | 4 (2.6) | 6 (2.6) | 0 (0.0) |
Others | 1 (0.7) | 1 (0.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
ITN Ownership | 121 (84.6) | 130 (82.3) | 130 (85.0) | 195 (84.8) | 143 (92.3) |
Slept under ITN the night before survey | 118 (82.5) | 128 (81.0) | 129 (84.3) | 194 (84.3) | 142 (91.6) |
Had a fever in this pregnancy | 62 (43.4) | 44 (27.8) | 27 (17.6) | 39 (17.0) | 33 (21.3) |
Treated for malaria in this pregnancy | 56 (39.2) | 73 (46.2) | 35 (22.9) | 60 (26.1) | 31 (20.0) |